As COVID Vaccines Head into Phase 3 Trials Big Pharma Prepares for Increase in Flu Vaccines for Fall
An article published in FiercePharma, a pharmaceutical marketing trade publication, is reporting that the National Institute of Health is preparing to test experimental COVID vaccines entering into phase 3 of development on over 90,000 people this summer. The three drug companies entering phase 3 trials are Moderna, AstraZeneca and Johnson & Johnson. Given the recent bad publicity Moderna received from the small sample size tested so far, one has to wonder if the drug companies will be transparent in releasing the results of these trials, both negative and any positive outcomes. Given the fact that the U.S. taxpayers are picking up the tab on these trials, the companies have a legal and moral obligation to be transparent in the results of these trials. Meanwhile, flu vaccine manufacturers are already preparing for this fall's flu season and planning on manufacturing more flu vaccines than they did last year. According to FiercePharma, the manufacturers are looking at "creative ways" of injecting more people, by setting up mobile clinics in parking lots, parks or community centers. I would not be surprised to see them giving them out in churches and other religious institutions as well. In another article published this week by Beth Snyder Bulik in FiercePharma, it is revealed that Big Pharma invests heavily in tracking social media conversations about COVID treatments and other drugs, and also in advertising and using "influencers" to get their message out. There can be no doubt now that Big Tech social media companies work with Big Pharma while suppressing any other natural treatments that would compete with them.